Skip to main content

Table 1 Patients’ characteristics at baseline (n = 1,070)

From: Effect of menopause on the modified Rodnan skin score in systemic sclerosis

Characteristic Value
Menopausal status, n (%)  
 Premenopausal 291 (28.1)
 Postmenopausal 744 (71.9)
Disease subtype, n (%)  
 Limited 675 (65.0)
 Diffuse 369 (35.0)
Age, mean (SD) 55.5 (11.7)
Disease duration, mean (SD) 11.2 (9.6)
Modified Rodnan skin score, mean (SD)  
 Overall 9.6 (9.1)
 Limited 5.3 (4.2)
 Diffuse 17.5 (10.1)
Race/ethnicity, n (%)  
 White 900 (84.3)
 Black 7 (0.7)
 Other 160 (15.0)
Ever smokers, n (%) 576 (53.8)
Medication exposure, n (%)  
 Oral contraceptives, current use 21 (2.0)
 Hormone replacement therapy, current use 86 (8.2)
 DMARDs, current use 183 (17.4)
 Cyclophosphamide, ever exposed 85 (8.0)
  1. DMARDs, disease-modifying antirheumatic drugs.